Atrial Arrhythmias in Patients with Severe COVID-19
Table 3
Arrhythmias, cardiomyocyte injury markers, and death between nonsevere and severe patients with COVID-19.
Variable
Nonsevere (N = 44)
Severe (N = 40)
value
Male/female (n)
18/26
26/14
0.03
Age (yrs)
55.20 ± 11.50
69.30 ± 11.60
<0.01
Hypertension (n)
16 (36.40)
18 (45)
0.42
Diabetes (n)
8 (18.20)
11 (27.50)
0.31
Hyperlipidemia (n)
2 (4.50)
0
0.50
CAD (n)
2 (4.50)
6 (15)
0.14
Thyroid disease (n)
1(2.30)
0
1.00
Cardiomyopathy (n)
0
0
1.00
HF (n)
1 (2.30)
4 (10)
0.19
Stroke (n)
3 (6.80)
6 (15)
0.30
COPD (n)
0
3 (7.50)
0.10
Lung cancer (n)
1 (2.30)
0
1.00
Liver disease (n)
3 (6.80)
4 (10)
0.70
Kidney disease (n)
1 (2.30)
3 (7.50)
0.34
Total heart rate (beats/24 hrs)
115342.27 (108373.00, 127819.90)
118109.70 (110108.50, 136861.30)
0.28
Maximum heart rate (bpm)
131.40 ± 18.30
127.40 ± 24.70
0.75
Minimum heart rate (bpm)
58.70 ± 6.90
57.00 ± 13.50
0.46
Mean heart rate (bpm)
80.60 ± 7.70
83.50 ± 13.10
0.70
PCA (beats/24 hrs)
6.4 (0.80, 25.60)
95.40 (6.10, 1410.40)
<0.01
NSAT (n/24 hrs)
0 (0, 1.10)
1.10 (0, 29.40)
0.14
AF (n)
0
4 (10.00)
0.05
PVC (beats/24 hrs)
2 (0, 32.00)
8.3 (1.00, 202.10)
0.97
NSVT (n/24 hrs)
0 (0, 0)
0 (0, 0)
0.66
AVB (n/24 hrs)
0
3 (7.50)
0.10
CKMB (ng/mL)
0.9 (0.60, 1.40)
1.5 (1.20, 4.00)
<0.01
hscTnI (ng/mL)
0.01 (0.01, 0.01)
0.01 (0.01, 0.03)
0.01
Myoglobin (ng/mL)
4.8 (3.30, 11.20)
15.0 (6.90, 95.00)
0.07
Death (n)
1 (2.30)
6 (15.00)
0.05
Data are expressed as mean (SD) or median (IQR) for continuous variables and number (%) for categorical variables. AF, atrial fibrillation; AVB, atrioventricular block; CKMB, creatine kinase isoenzyme; COVID-19, novel coronavirus disease 2019; hscTnI, high-sensitive cardiac troponin I; PAC, premature atrial contracts; PVC, premature ventricular contracts; NSAT, nonsustained atrial tachycardia; NSVT, nonsustained ventricular tachycardia.
